HIV/AIDS
HIV/AIDS is a chronic, life-threatening condition caused by the human immunodeficiency virus (HIV). HIV interferes with the body’s immune system, damaging its ability to effectively fight off viruses, bacteria and fungi. This damaged immune system puts patients more at risk to dangerous infections the body would normally resist and certain types of cancer.
When acquired immune deficiency syndrome (AIDS) was first identified about 25 years ago, there were few treatment options. Now, while there are still no cures, drug treatments have turned HIV into a treatable disease for many. Today there are 33.2 million people living with HIV/AIDS around the world, according to the Joint United Nations Programme on HIV/AIDS.
Bristol-Myers Squibb has long been a leader in developing innovative HIV/AIDS medications and treatments and will continue to make HIV/AIDS research a top priority.
Our company allocates substantial R&D resources to developing new medicines and treatments in the global fight against HIV/AIDS. We are exploring new ways to attack the AIDS virus and new ways to help make treatments simpler for patients to take.